Mylan Keppra Seizure AttorneysGeneric Keppra, Manufactured by Mylan
Mylan is one of the world's leading manufacturers of generic drugs, including Levetiracetam (LVT). In 2009, Mylan was given final approval by the Food and Drug Administration (FDA) to manufacture a generic substitute for the anti-seizure medication, Keppra, developed by UCB Pharmaceuticals Inc. and marketed to epilepsy sufferers. However, since the generic drug became available to the general public, users of Mylan's product have reported less than satisfactory results, with many complaining that the generic medication is not as effective as brand name Keppra. While generic drugs are not exactly the same as their brand name counterparts, it should be reasonably expected that their effectiveness in treating medical conditions, in this case epileptic seizures, is similar to that of the name brand drug. Mylan's Keppra, like all generic drugs, is supposed to be a bioequivalent substitute for Keppra. However, according to FDA guidelines, a bioequivalent does not have to be an exact duplicate, but may instead deviate from the brand name medication it is mimicking by as much as 20%. While active ingredients are the same, inactive ingredients that help bind the medication together are not. Herein lays the issue consumers of Mylan's generic version of Keppra face. With a variation of inactive ingredients, the effectiveness and result of using Mylan's LVT affects users differently, resulting in some cases where the intensity or frequency of seizures actually increases. According to numerous user complaints, the transition from Keppra a generic medication, such as Mylan's LVT, is often hit or miss. Some users report a smooth transition, experiencing little to no side effects created by the change. As for others, there have been numerous instances of breakthrough seizures shortly after switching to generic Keppra by Mylan, many also report a host of other debilitating side effects, even in cases where the user experienced no side effects on the brand name. While the FDA may claim that generic substitutes are just as effective in treating conditions like epilepsy, Mylan generic Keppra consumer horror stories offer evidence to the contrary, essentially stating that a bioequivalent anti-epileptic drug is not always as effective as the drug it is emulating. Contact a Mylan Keppra Seizure LawyerSometimes, generic substitutes perform just as well as the name brand drugs do. However, this is not always the case. If you have recently switched from Keppra to the generic manufactured by Mylan, and are experiencing debilitating consequences as a result, please contact the experienced Mylan Keppra lawsuit attorneys at Anapol Schwartz at (866) 735-2792 for a free consultation of your case. CALL TODAY 866.735.2792 |
Copyright © 2004-2012 All rights reserved. Anapol Schwartz - Philadelphia Mylan Generic Keppra Lawyers - Pennsylvania Mylan Keppra Seizure Attorneys - Personal Injury and Pharmaceutical Liability Law Firm.
Pennsylvania Generic Mylan Keppra Lawsuits Disclaimer: This website is dedicated to providing public information regarding Mylan Keppra seizures, breakthrough seizures, generic LVT drugs, and other Mylan Keppra side effects and legal information. None of the information on this site is intended to be formal legal advice, nor the formation of a lawyer or attorney client relationship. Please contact a Philadelphia Mylan Keppra lawyer or Pennsylvania Generic Keppra injury attorney at our law firm for information regarding your particular case. This website is not intended to solicit clients outside the States of New Jersey, Pennsylvania, West Virginia, and Ohio.
Website, SEO and Legal Internet Marketing by: SLS Consulting | Sitemap